Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $16.25

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received a consensus recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $17.08.

A number of brokerages recently weighed in on MD. Truist Financial upped their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Deutsche Bank Aktiengesellschaft upped their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a report on Monday, November 4th. Jefferies Financial Group increased their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Macquarie initiated coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target on the stock.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $15.57 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The firm has a fifty day moving average of $13.89 and a two-hundred day moving average of $12.96. The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of -5.09, a PEG ratio of 1.43 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. As a group, equities research analysts predict that Pediatrix Medical Group will post 1.26 EPS for the current year.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds have recently added to or reduced their stakes in MD. CWM LLC boosted its position in Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after buying an additional 3,681 shares in the last quarter. Creative Planning boosted its position in Pediatrix Medical Group by 48.3% in the third quarter. Creative Planning now owns 30,662 shares of the company’s stock valued at $355,000 after buying an additional 9,991 shares in the last quarter. Everence Capital Management Inc. bought a new position in shares of Pediatrix Medical Group during the third quarter valued at $149,000. Nisa Investment Advisors LLC raised its stake in shares of Pediatrix Medical Group by 352.4% during the third quarter. Nisa Investment Advisors LLC now owns 21,513 shares of the company’s stock valued at $249,000 after acquiring an additional 16,758 shares during the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of Pediatrix Medical Group by 14.1% during the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after acquiring an additional 63,581 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.